BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26165073)

  • 1. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
    Kawai T; Yagi K; Moriyasu F
    Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance.
    Bardhan KD
    Yale J Biol Med; 1996; 69(3):211-24. PubMed ID: 9165690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid pump blockers: what are their current therapeutic roles?
    Arens MJ; Dent J
    Baillieres Clin Gastroenterol; 1993 Mar; 7(1):95-128. PubMed ID: 8097414
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and abuse of histamine H2-receptor antagonists.
    Milton-Thompson GJ
    J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
    [No Abstract]   [Full Text] [Related]  

  • 6. The Effect of H
    Shim YK; Kim N
    Korean J Gastroenterol; 2017 Jul; 70(1):4-12. PubMed ID: 28728310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H2-receptor antagonists in perspective.
    Malagelada JR; Cortot A
    Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor failure--what are the therapeutic options?
    Fass R
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
    Yang Z; Wu Q; Liu Z; Wu K; Fan D
    Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Chassany O; Bergmann JF
    Rev Prat; 1998 Apr; 48(8):893-8. PubMed ID: 11767336
    [No Abstract]   [Full Text] [Related]  

  • 11. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical treatments of reflux esophagitis - Proton pump inhibitors and histamine H2 receptor antagonists -].
    Kinoshita Y; Ishimura N
    Nihon Rinsho; 2016 Aug; 74(8):1304-1310. PubMed ID: 30562433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
    Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
    Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of acid-related disorders in the United States.
    Brown M; Yang RD
    Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease (GERD): is there more to the story?
    Vesper BJ; Altman KW; Elseth KM; Haines GK; Pavlova SI; Tao L; Tarjan G; Radosevich JA
    ChemMedChem; 2008 Apr; 3(4):552-9. PubMed ID: 18076011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of gastric acid secretion in health and disease.
    Schubert ML; Peura DA
    Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I; Tutuian R; Castell DO
    J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients.
    Glew CM; Rentler RJ
    J Am Med Dir Assoc; 2007 Nov; 8(9):607-9. PubMed ID: 17998118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.